Cellular immune response and T cell epitope mapping of Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP and Pfs48/45) in individuals naturally exposed to malaria in Brazilian Amazon

Baptista, B. D. O., Soares, I. F., de Souza, H. A. D. S., Barros, J. P. D., Riccio, E. K. P., Martorano, R. M., Rodrigues-da-Silva, R. N., Amoah, L. E., Singh, S. K., Theisen, M., Lima-Junior, J. D. C., Totino, P. R. R., Daniel-Ribeiro, C. T. & Pratt-Riccio, L. R., 8 May 2026, In: Vaccines. 14, 5, 24 p., 423.

Research output: Contribution to journal › Journal article › Research › peer-review

Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection study

ProC6C Study Group, 2026, In: The Lancet Infectious Diseases. 26, 5, p. 451-463

Research output: Contribution to journal › Journal article › Research › peer-review

Magnitude and durability of ProC6C-AlOH/Matrix-M^tm vaccine-induced malaria transmission-blocking antibodies in Burkinabe adults from a Phase 1 randomized trial

Naghizadeh, M., Miura, K., Addo Ofori, E., Long, C., Sagara, I., Tiono, A. B., Plieskatt, J. & Theisen, M., 2025, In: Human vaccines & immunotherapeutics. 21, 1, 12 p., 2488075.

Research output: Contribution to journal › Journal article › Research › peer-review

Novel, fully human, anti-PfCSP antibodies with potent antimalarial activity using a phage display based strategy

Parveen, S., Rath, P. P., Tabrez, S., Khan, S., Singh, P., Arkam, S. Z., Verma, S., Ahmad, S., Singh, S. K., Junaid, I. T., Kumar, D., Theisen, M., Gupta, D., Mohmmed, A., Salunke, D. M., Singh, A. P. & Malhotra, P., 2025, In: Vaccine. 54, 126993.

Research output: Contribution to journal › Journal article › Research › peer-review

Wider antibody breadth against multiple Plasmodium falciparum antigens is associated with reduced risk of malaria in a transmission hotspot in southern Ghana

Kyei-Baafour, E., Kusi, K. A., Owusu-Yeboa, E., Issahaque, Q. A., Kumordjie, S., Authur, F. K. N., Dwomoh, D., Singh, S. K., Dodoo, D., Theisen, M. & Adu, B., 2025, In: International Journal of Infectious Diseases. 153, 7 p., 107804.

Research output: Contribution to journal › Journal article › Research › peer-review

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

Alkema, M., Smit, M. J., Marin-Mogollon, C., Totté, K., Teelen, K., van Gemert, G. J., van de Vegte-Bolmer, M., Mordmüller, B. G., Reimer, J. M., Lövgren-Bengtsson, K. L., Sauerwein, R. W., Bousema, T., Plieskatt, J., Theisen, M., Jore, M. M. & McCall, M. B. B., 2024, In: BMC Medicine. 22, 1, 12 p., 170.

Research output: Contribution to journal › Journal article › Research › peer-review

A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults

Tiono, A. B., Plieskatt, J. L., Ouedraogo, A., Soulama, B. I., Miura, K., Bougouma, E. C., Naghizadeh, M., Barry, A., Yaro, J. B. B., Ezinmegnon, S., Henry, N., Ofori, E. A., Adu, B., Singh, S. K., Konkobo, A., Lövgren Bengtsson, K., Diarra, A., Carnrot, C., Reimer, J. M. & Ouedraogo, A. & 6 others, Tienta, M., Long, C. A., Ouedraogo, I. N., Sagara, I., Sirima, S. B. & Theisen, M., 2024, In: The Journal of Clinical Investigation. 134, 7, 15 p., e175707.

Research output: Contribution to journal › Journal article › Research › peer-review

Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP

Plieskatt, J., Bang, P., Wood, G. K., Naghizadeh, M., Singh, S. K., Jore, M. M. & Theisen, M., 2024, In: Vaccine. 42, 8, p. 1980-1992

Research output: Contribution to journal › Journal article › Research › peer-review